TidalSense Raises £19 Million To Accelerate COPD Diagnostic Technology
By Amit Chowdhry ● Yesterday at 4:56 PM
TidalSense announced it has raised £19 million to accelerate the company's team, technology, and its ability to bring N-Tidal Diagnose, its diagnostic test for chronic obstructive pulmonary disease, to more patients. The round was backed by Cross-Border Impact Ventures, BGF, Airstream Capital, and Foresight Group, a group of investors spanning healthcare-focused and growth-stage capital providers.